Kingworld Medicines Group Limited Stock

Equities

1110

KYG5268M1006

Pharmaceuticals

Market Closed - Hong Kong S.E. 04:08:15 2024-04-18 am EDT 5-day change 1st Jan Change
0.51 HKD 0.00% Intraday chart for Kingworld Medicines Group Limited +2.00% -19.05%

Financials

Sales 2021 847M 117M 917M Sales 2022 958M 132M 1.04B Capitalization 467M 64.57M 506M
Net income 2021 30M 4.14M 32.46M Net income 2022 22M 3.04M 23.8M EV / Sales 2021 0.5 x
Net Debt 2021 40.55M 5.6M 43.88M Net Debt 2022 34.51M 4.77M 37.34M EV / Sales 2022 0.52 x
P/E ratio 2021
12.4 x
P/E ratio 2022
20 x
Employees 1,002
Yield 2021
3.15%
Yield 2022
2.9%
Free-Float 33.63%
More Fundamentals * Assessed data
Dynamic Chart
Kingworld Medicines Group Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 28 June 2024 CI
Kingworld Medicines Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Kingworld Medicine Expects Up to 75% Profit Jump in 2023; Shares Up 6% MT
Kingworld Medicines Group Limited Provides consolidated Earnings Guidance for the Year Ended 31 December 2023 CI
Kingworld Medicines Group Limited Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Kingworld Medicines Subsidiary Buys Shares in Taiko Pharmaceutical MT
Kingworld Medicines Group Expects Up to 40% Rise in H1 Profit MT
Kingworld Medicines Group Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended 30 June 2023 CI
Kingworld Medicines Group Limited Approves Final Dividend for the Year Ended 31 December 2022 CI
Kingworld Medicines to Invest 832 Million Yen in Taiko Pharmaceutical MT
Kingworld Medicines to Grant 3.5 Million Awarded Shares Under 2019 Scheme MT
Kingworld Medicines Group Limited Proposes Ordinary Final Dividend for the Year Ended 31 December 2022, Payable on 30 June 2023 CI
Kingworld Medicines Group Limited Reports Earnings Results for the Full Year Ended December 31, 2022 CI
KIngworld Medicines Group Acquires 60% Stake in Innopharm MT
Kingworld Medicines Completes Topping Out Process of Longde Health Industrial Park MT
More news
1 week+2.00%
Current month-1.92%
1 month-13.56%
3 months-13.56%
6 months-32.00%
Current year-19.05%
More quotes
1 week
0.50
Extreme 0.5
0.51
1 month
0.49
Extreme 0.49
0.64
Current year
0.49
Extreme 0.485
0.67
1 year
0.49
Extreme 0.485
0.92
3 years
0.37
Extreme 0.365
1.10
5 years
0.37
Extreme 0.365
1.19
10 years
0.37
Extreme 0.365
2.90
More quotes
Managers TitleAgeSince
Chief Investment Officer 42 15-07-31
Comptroller/Controller/Auditor 63 -
Comptroller/Controller/Auditor 64 09-06-24
Members of the board TitleAgeSince
Director/Board Member 56 10-11-04
Founder 61 95-12-31
Founder 66 95-12-31
More insiders
Date Price Change Volume
24-04-18 0.51 0.00% 1,028,000
24-04-17 0.51 +2.00% 1,012,000
24-04-16 0.5 0.00% 20,000
24-04-15 0.5 0.00% 16,000
24-04-12 0.5 0.00% 20,000

Delayed Quote Hong Kong S.E., April 18, 2024 at 04:08 am EDT

More quotes
Kingworld Medicines Group Limited is an investment holding company principally engaged in the distribution and sales of pharmaceutical and healthcare products. The Company’s products include cough and phlegm relieving, gastrointestinal, vitamin, orthopedics, cardiovascular, influenza and others. The Company operates through two business segments. The Distribution Sales of Pharmaceutical and Healthcare Products segment is engaged in the distribution and sales of branded imported pharmaceutical and healthcare products primarily in Hong Kong and the People’s Republic of China (PRC). The Manufacturing and Sales of Electrotherapeutic and Physiotherapeutic Devices and General Medical Examination Devices segment is engaged in the manufacture and sales of electrotherapeutic and physiotherapeutic devices, as well as general medical examination devices in the PRC.
More about the company